Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis
Clinical trial NCT02054572 · COMPLETED
Trial details
- NCT number
- NCT02054572
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-07
- Primary completion
- 2014-04-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.